ACS Biomaterials Science & Engineering · 2023 · 16 citations · 30 references
PharmacyBioengineeringPharmaceuticsChemotherapyDrug DeliveryNanoparticle Drug DeliveryDrug EncapsulationMicroneedle-based DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsPhotothermal TherapyCancer Photothermal TherapyDissolving Microneedle PatchesDrug-loaded BiomaterialsMicellesMicroneedle Delivery SystemsMicroneedle FabricationMicroneedlesNanoparticles
Melanoma is a malignancy of the skin that is resistant to conventional treatment, necessitating the development of effective and safe new therapies. The percutaneous microneedle (MN) system has garnered increasing interest as a viable treatment option due to its high efficacy, minimal invasiveness, painlessness, and secure benefits. In this investigation, a sensitive MN system with multiple functions was created to combat melanoma effectively. This MN system utilized polyvinylpyrrolidone (PVP) as microneedle substrates and biocompatibility panax notoginseng polysaccharide (PNPS) as microneedle tips, which encapsulated PVP-stabilized CuO 2 nanoparticles as a therapeutic agent and disulfiram-containing F127 micelles to enhance the tumor treatment effect. The MN system had sufficient mechanical properties to pierce the skin, and the excellent water solubility of PNPS brought high-speed dissolution properties under the bio conditions, allowing the MNs to effectively penetrate the skin and deliver the CuO 2 nanoparticles as well as the drug-loaded micelles to the melanoma site. CuO 2 nanoparticles released by the MN system generated Cu 2+ and H 2 O 2 in the tumor acidic environment to achieve self-supply of hydrogen peroxide to chemodynamic therapy (CDT). In addition, Cu 2+ was chelated with disulfiram to produce CuET, which killed tumor cells. And the MN system had excellent near-infrared (NIR) photothermal properties due to the loading of CuO 2 nanoparticles and induced localized thermotherapy in the melanoma region to further inhibit tumor growth. Thus, the designed MN system accomplished effective tumor suppression and minimal side effects in vivo via combined therapy, offering patients a safe and effective option for melanoma treatment.
30
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations
Life Sciences, Immunology, Oncology +17
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
Ardeshir R. Rastinehad, Harry Anastos, Ethan Wajswol et al. · Proceedings of the National Academy of Sciences · 2019 · 874 citations · Full text
Engineering, Biomedical Engineering, Biomedical Sciences +17
Recent progress of chemodynamic therapy-induced combination cancer therapy
Xianwen Wang, Xianyan Zhong, Zhuang Liu et al. · Nano Today · 2020 · 706 citations
Medicine, Oncology, Pharmacology +14